Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria

Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria

Introduction. Several point-of-care tests (POCT) are available for the diagnosis of bladder cancer (BC). We evaluate the impact of HU (hematuria) on performance of POCTs. Materials and Methods. Urine from 10 donors was diluted with blood from 0.5 to 0.00625%. BladderCheckR, BTAstatR, BCMR, and BTAR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advances in Urology 2011-01, Vol.2011 (2011), p.325-329
Hauptverfasser: Hennenlotter, Joerg, Huber, Severine, Todenhöfer, Tilman, Kuehs, Ursula, Schilling, David, Aufderklamm, Stefan, Gakis, Georgios, Schwentner, Christian, Stenzl, Arnulf
Format: Artikel
Sprache:eng
Schlagworte:
Clinical Study
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction. Several point-of-care tests (POCT) are available for the diagnosis of bladder cancer (BC). We evaluate the impact of HU (hematuria) on performance of POCTs. Materials and Methods. Urine from 10 donors was diluted with blood from 0.5 to 0.00625%. BladderCheckR, BTAstatR, BCMR, and BTAR tests were applied. Tests were additionally conducted in 54 patients with HU. HU was stratified according to the amount of erythrocytes (RBC)/μL using two systems: (1) no HU; mild microscopic HU; severe microscopic HU; gross HU; (2) I
ISSN:1687-6369
1687-6377
DOI:10.1155/2011/937561